Global expenditures on healthcare are approaching seven trillion US dollars a year, or roughly 10 per cent of the world’s gross domestic product. More than 70 per cent of these expenditures occur in North America and Europe alone. Not surprisingly, opportunities are immense and growing in the health and life sciences industry, for businesses that include: pharmaceutical and device manufacturers; research and development organisations; information technology companies; providers; clinicians; insurers and entrepreneurs of every stripe.
These opportunities are local, national and global. A 100-bed community hospital in Kansas City wants to form a joint venture for an ambulatory surgery centre with 11 cardiologists from St Louis. A children’s hospital in Abu Dhabi wants to partner with a teaching hospital in Paris. A device manufacturer headquartered in Bonn wishes to market its products in Hong Kong. A Russian pharmaceutical company seeks approval from the US Food and Drug Administration for a new anti-coagulant. An e-health company headquartered in Barcelona wants to license its health records software to an IT consultant in Kampala. The list may be long, but the number of law firms that can handle this range of matters is not.
The firm must have a presence, on the ground and around the world. The firm must have a deep bench of lawyers who have spent decades immersed in the health and life sciences sector, helping organisations navigate continuously evolving political, regulatory and economic landscapes. The firm must understand each jurisdiction’s health care delivery system — from manufacturer to distributor to provider to patient to payor to policy maker — and the firm must be able to provide each of these players with the full range of strategic transactional, regulatory and dispute resolution counseling services.
With offices in 79 locations in 52 countries across four continents, and with more than 100 lawyers, consultants and policy professionals who have spent their entire professional careers exclusively counseling health care life sciences organisations, Dentons is proud to be that firm.
This information was sourced from the Dentons website.
News from Dentons
News from The Lawyer
Briefings from Dentons
The UK government has published application criteria and terms for the 14th onshore oil and gas licensing round, accompanied by new guidance.
Calculations on ISDA close-out: Lehman Brothers Finance SA (in liquidation) v Sal Oppenheim jr & cie KGAA
This case provides further guidance in relation to how payment on early termination of a 1992 ISDA Master Agreement should be calculated where automatic early termination applies.
Analysis from The Lawyer
The continent’s boom in natural resources and renewable energy is sparking an infrastructure drive
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.